Nuvalent (NUVL) News Today $72.16 -5.07 (-6.56%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$73.08 +0.92 (+1.27%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial ResultsAugust 7 at 6:30 AM | prnewswire.comNuvalent (NUVL) Projected to Post Quarterly Earnings on ThursdayAugust 7 at 2:15 AM | americanbankingnews.comNuvalent (NUVL) Projected to Post Earnings on ThursdayAugust 7 at 2:14 AM | marketbeat.comXTX Topco Ltd Acquires New Stake in Nuvalent, Inc. (NASDAQ:NUVL)August 5 at 3:55 AM | marketbeat.comJefferies Financial Group Inc. Acquires 23,795 Shares of Nuvalent, Inc. (NASDAQ:NUVL)August 4, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Given Average Rating of "Buy" by BrokeragesAugust 4, 2025 | americanbankingnews.comNuvalent, Inc. (NASDAQ:NUVL) Given Average Recommendation of "Buy" by BrokeragesAugust 4, 2025 | marketbeat.comTD Asset Management Inc Purchases 23,412 Shares of Nuvalent, Inc. (NASDAQ:NUVL)August 3, 2025 | marketbeat.comNuvalent (NUVL) Gets a Buy from Goldman SachsJuly 30, 2025 | theglobeandmail.comVictory Capital Management Inc. Has $1.88 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL)July 30, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Sells 11,308 Shares of Nuvalent, Inc. (NASDAQ:NUVL)July 29, 2025 | marketbeat.comNuvalent Doses First Patient in Phase 3 ALKAZAR Trial for Neladalkib in ALK-Positive NSCLCJuly 25, 2025 | msn.comLegato Capital Management LLC Has $629,000 Holdings in Nuvalent, Inc. (NASDAQ:NUVL)July 25, 2025 | marketbeat.comNew York State Common Retirement Fund Buys 3,965 Shares of Nuvalent, Inc. (NASDAQ:NUVL)July 25, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Given Outperform Rating at WedbushJuly 21, 2025 | marketbeat.comNuvalent Initiates Phase 3 ALKAZAR Clinical TrialJuly 21, 2025 | tipranks.comNuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLCJuly 21, 2025 | prnewswire.comNuvalent, Inc. (NASDAQ:NUVL) CFO Alexandra Balcom Sells 5,300 SharesJuly 18, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) CFO Sells $1,250,970.00 in StockJuly 18, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) CEO Sells $2,221,290.00 in StockJuly 18, 2025 | marketbeat.comAlexandra Balcom Sells 5,300 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockJuly 18, 2025 | insidertrades.comEdgestream Partners L.P. Boosts Position in Nuvalent, Inc. (NASDAQ:NUVL)July 16, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Insider Sells $174,088.20 in StockJuly 11, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Insider Sells $439,890.00 in StockJuly 11, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Receives Average Rating of "Buy" from AnalystsJuly 10, 2025 | marketbeat.comNuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung CancerJuly 6, 2025 | msn.comViola Zhu - NUVL | Nuvalent Inc. Cl A - Wall Street JournalJuly 3, 2025 | wsj.comNuvalent (NASDAQ:NUVL) Stock Rating Upgraded by The Goldman Sachs GroupJuly 2, 2025 | marketbeat.comAlexandra Balcom Sells 20,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockJuly 2, 2025 | insidertrades.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) CFO Sells 20,000 Shares of StockJuly 1, 2025 | marketbeat.comHenry E. Pelish Sells 2,170 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockJune 28, 2025 | insidertrades.comNuvalent, Inc. (NUVL) Latest Stock News & Headlines - Yahoo FinanceJune 27, 2025 | finance.yahoo.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells 2,170 Shares of StockJune 27, 2025 | marketbeat.comHenry E. Pelish Sells 8,630 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockJune 27, 2025 | marketbeat.comNuvalent FY2026 EPS Estimate Reduced by Leerink PartnrsJune 27, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for Nuvalent EarningsJune 26, 2025 | marketbeat.comNuvalent price target raised to $140 from $125 at LeerinkJune 26, 2025 | finance.yahoo.comNuvalent price target raised to $130 from $110 at H.C. WainwrightJune 26, 2025 | finance.yahoo.comNuvalent (NASDAQ:NUVL) Price Target Raised to $112.00June 25, 2025 | marketbeat.comNuvalent Announces Timing of Pivotal Data for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC from ARROS-1 Clinical Trial of Zidesamtinib - MorningstarJune 24, 2025 | morningstar.comMNuvalent reports positive results from lung cancer treatment trialJune 24, 2025 | msn.comLeerink Partners Boosts Nuvalent (NASDAQ:NUVL) Price Target to $140.00June 24, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for Nuvalent (NASDAQ:NUVL) Stock PriceJune 24, 2025 | marketbeat.comNuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLCJune 24, 2025 | prnewswire.comNuvalent Announces Timing of Pivotal Data for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC from ARROS-1 Clinical Trial of ZidesamtinibJune 23, 2025 | prnewswire.comNuvalent Appoints Christy Oliger to Board of DirectorsJune 18, 2025 | prnewswire.comGAMMA Investing LLC Boosts Stake in Nuvalent, Inc. (NASDAQ:NUVL)June 18, 2025 | marketbeat.comNuvalent’s SWOT analysis: brain-penetrant TKIs poised to reshape NSCLC stockJune 15, 2025 | investing.comNuvalent, Inc. (NASDAQ:NUVL) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 15, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Insider Henry E. Pelish Sells 200 SharesJune 11, 2025 | insidertrades.com Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVL Media Mentions By Week NUVL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVL News Sentiment▼0.410.39▲Average Medical News Sentiment NUVL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVL Articles This Week▼96▲NUVL Articles Average Week Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News Today INSM News Today TEVA News Today GMAB News Today MRNA News Today RDY News Today QGEN News Today VTRS News Today ASND News Today BBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NUVL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
